Sumaya Castillo-Florez

Publications by Year

Research Areas

Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Genetic Associations and Epidemiology, Diabetes Management and Research

Most-Cited Works

• → Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela(2005)149 cited
• → C-reactive protein is elevated in obese patients with the metabolic syndrome(2005)139 cited
• → Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study(2019)124 cited
• → Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type 2 Diabetes(2010)108 cited
• → Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)(2019)101 cited
• → Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study(2021)95 cited
• → The Impact of Physical Activity on the Prevention of Type 2 Diabetes: Evidence and Lessons Learned From the Diabetes Prevention Program, a Long-Standing Clinical Trial Incorporating Subjective and Objective Activity Measures(2020)69 cited
• → Beyond the Obesity Paradox in Diabetes(2012)54 cited
• → Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population(2005)45 cited
• → Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience(2022)29 cited